Grabska-Kobylecka Izabela, Nowak Dariusz, Wlodarczyk Anna, Bialasiewicz Piotr
Department of Clinical Physiology, Medical University of Lodz, Lodz, Poland.
Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
Clin Rheumatol. 2016 Nov;35(11):2847-2850. doi: 10.1007/s10067-016-3358-y. Epub 2016 Jul 27.
Henoch-Schonlein purpura (HSP) is a generalized form of IgA-mediated vasculitis that usually spares pulmonary circulation. Nevertheless, it is conceivable that subclinical changes at the HSP onset may lead to lung impairment in the long term. Therefore, we decided to follow a group of HSP patients for 4 years to monitor changes in pulmonary function. A group of 11 children and adolescents diagnosed with HSP without apparent pulmonary involvement was subjected to pulmonary function tests (PFTs), i.e., spirometry, body plethysmography, and diffusing capacity for CO (DLCO); these tests were repeated after 48 months. No significant impairment was observed in variables of spirometry, body plethysmography, and DLCO expressed as % of predicted values (% predicted) after 4 years. Specifically, no significant change in DLCO, corrected for blood hemoglobin concentration was noted, i.e., 79.3 ± 10.1 vs. 81.6 ± 14.7 % predicted at the beginning and the end of the study, respectively. IgA vasculitis seems to spare pulmonary circulation as we found no impairment in PFTs within the study time frame and a median of almost 6 years from the first episode of the disease.
过敏性紫癜(HSP)是一种全身性IgA介导的血管炎,通常不累及肺循环。然而,可以想象,HSP发病时的亚临床变化可能长期导致肺功能损害。因此,我们决定对一组HSP患者进行4年随访,以监测肺功能变化。对一组11名诊断为HSP且无明显肺部受累的儿童和青少年进行了肺功能测试(PFTs),即肺活量测定、体容积描记法和一氧化碳弥散量(DLCO);48个月后重复这些测试。4年后,以预测值百分比(%预测)表示的肺活量测定、体容积描记法和DLCO变量未观察到显著损害。具体而言,校正血红蛋白浓度后的DLCO无显著变化,即研究开始和结束时分别为预测值的79.3±10.1%和81.6±14.7%。IgA血管炎似乎不累及肺循环,因为我们在研究时间范围内以及自疾病首次发作起中位数近6年的时间里均未发现PFTs有损害。